Viking Therapeutics, Inc. (VKTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Viking Therapeutics, Inc. (VKTX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

VKTX Cash Flow Statement

Viking Therapeutics, Inc. (VKTX) cash flow statement — 14-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-138.19M	-125.17M	-113.98M	-85.29M	-94M	-47.06M	-52.33M	-31.18M	-21.96M	-28.51M	-6.13M	-17.64M	-19.66M	-11.44M	-24.64M	-10.93M	-13.5M	-13.44M	-10.53M	-12.35M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-47.01%	-165.98%	-117.8%	-173.53%	-328.03%	-65.05%	-753.13%	-76.76%	-11.72%	-149.35%	75.11%	-61.45%	-45.63%	14.93%	-134.03%	11.53%	-23.55%	-0.06%	3.18%	-125.12%
Net Income	-183.19M	-128.02M	-158.32M	-157.66M	-90.79M	-65.56M	-45.63M	-35.42M	-24.94M	-22.25M	-27.36M	-24.61M	-22.53M	-19.23M	-19.53M	-19.56M	-15.77M	-17.43M	-16.1M	-12.36M
Depreciation & Amortization	0	157K	85K	94K	114K	112K	111K	110K	87K	75K	74K	74K	73K	73K	72K	72K	142K	0	77K	76K
Stock-Based Compensation	17.89M	11.13M	10.34M	8.59M	7.34M	13.55M	11.35M	5.67M	8.98M	7.08M	7.98M	4.08M	4.48M	4.62M	3.57M	2.16M	1.94M	2.22M	2.36M	1.43M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	-3.15M	0	0	0	0	0	0	0
Other Non-Cash Items	-547K	-804K	-1.29M	-1.79M	-2.02M	-2.36M	-3.1M	-4M	-5.06M	-5.41M	-2.78M	-2.67M	12K	-1.92M	-349K	-75K	195K	511K	686K	767K
Working Capital Changes	27.65M	-7.64M	35.22M	65.48M	-8.64M	7.2M	-15.06M	2.46M	-1.03M	-8.01M	15.95M	5.48M	1.46M	5.02M	-8.4M	6.48M	-3K	1.26M	2.45M	-2.27M
Change in Receivables	0	120K	936K	413K	2.2M	-11K	2.47M	-646K	1.35M	-157K	655K	-101K	0	-67K	243K	115K	0	243K	105K	594K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	13.12M	1.83M	13.93M	48.84M	-1.08M	-2.21M	-2.11M	9.56M	-10.84M	5.86M	-2.29M	1.8M	100K	1.81M	-4.73M	5.39M	-2.96M	2.95M	1.71M	-1.39M
Cash from Investing	92.52M	109.43M	54.19M	75.61M	160.03M	42.51M	63.24M	6.58M	25.9M	-126.06M	-459.79M	35.73M	-12.53M	-204.48M	2.2M	7.26M	26.89M	18.98M	1.62M	27.41M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	125.69M	0	0	165.99M	0	0	0	0	0	0	-12.53K	0	2.2K	0	26.89K	0	0	0
Cash from Financing	597.55M	23.59M	12.08M	75.1M	480K	507K	349K	1M	2.52M	2.9M	606.04M	188K	-74K	267.08M	4.18M	10.75M	10K	-1.59M	-5.01M	47K
Debt Issued (Net)	251M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	346.55M	1.01M	450K	1.16M	480K	507K	349K	-46.66M	46.66M	-25K	597.12M	269.95M	1.9M	272.49M	-1.71M	128K	10K	-1.67M	-4.51M	47K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-37K	0	0	-1.67M	-5.12M	0
Other Financing	0	22.57M	11.63M	73.95M	0	0	0	47.66M	-44.14M	2.93M	8.92M	-269.76M	-1.97M	-5.41M	5.9M	10.62M	0	84K	-499K	0
Net Change in Cash	551.85M	7.63M	-47.69M	65.43M	66.5M	-4.06M	11.26M	-23.67M	6.43M	-151.66M	140.06M	18.33M	-32.33M	51.16M	-18.27M	7.22M	13.18M	3.77M	-13.92M	15.11M
Free Cash Flow	-138.19M	-125.17M	-113.98M	-85.29M	-94M	-47.06M	-52.33M	-31.18M	-21.96M	-28.51M	-6.13M	-17.64M	-19.66M	-11.44M	-24.64M	-10.93M	-13.5M	-13.44M	-10.53M	-12.35M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-47.01%	-165.98%	-117.8%	-173.53%	-328.03%	-65.05%	-753.13%	-76.76%	-11.72%	-149.35%	75.11%	-61.45%	-45.63%	14.93%	-134.03%	11.53%	-23.55%	-0.06%	3.18%	-125.12%
FCF per Share	-1.17	-1.08	-0.99	-0.75	-0.84	-0.42	-0.47	-0.28	-0.20	-0.26	-0.06	-0.18	-0.20	-0.12	-0.31	-0.14	-0.18	-0.17	-0.14	-0.16
FCF Conversion (FCF/Net Income)	0.75x	0.98x	0.72x	0.54x	1.04x	0.72x	1.15x	0.88x	0.88x	1.28x	0.22x	0.72x	0.87x	0.59x	1.26x	0.56x	0.86x	0.77x	0.65x	1.00x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0